Inhalable Nanobodies Can Cure Coronavirus

The new nanobody-based substance is inhaled like a vapor, but can work regardless of its entry point to the respiratory system. It employs single-domain antibody fragments, which are cheaper to produce than traditional monoclonal antibodies. The treatment can also be aerosolized to create a whole-body exposure, which would enable rapid inoculation of populations to protect against COVID-19 coronavirus and its variants.